TD Cowen lowered the firm’s price target on Enovix (ENVX) to $7 from $10 and keeps a Hold rating on the shares. The firm said the company is on track to deliver custom cells for smartphones later this year with first qual deliveries scheduled in 2Q.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENVX:
- Enovix’s Breakthrough in Energy Density and Strategic Expansion Positions It as a Compelling Buy
- Enovix: Strong Growth Potential and Strategic Advancements Justify Buy Rating
- Enovix Corporation Reports Q1 2025 Financial Results
- Enovix Hold Rating: Balancing Technological Progress and Financial Challenges Amidst Intensifying Competition
- Enovix reports Q1 EPS (12c), consensus (17c)